Quarterly report pursuant to Section 13 or 15(d)

NET LOSS PER SHARE - Summary Of Diluted Shares Outstanding (Detail)

v3.22.2
NET LOSS PER SHARE - Summary Of Diluted Shares Outstanding (Detail) - shares
 3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Series C Convertible Preferred Stock        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of earnings per share (in shares) 0 2,520,368 0 2,520,368
Stock Options        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of earnings per share (in shares) 0 432,500 0 432,500
Common stock issued under the Backstop Agreement        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of earnings per share (in shares) 9,600,031 0 9,600,031 0
Restricted stock grants with only service conditions        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of earnings per share (in shares) 3,441,651 0 3,275,885 0